OpenRegistry
Companies House/Oxford/Company profile

DARK BLUE THERAPEUTICS LTD

Active
12645831·incorporated 2020-06-04

DARK BLUE THERAPEUTICS LTD is an active UK private limited company, incorporated on 4 June 2020 at Companies House (number 12645831; OpenRegistry canonical ID GB-12645831-dark-blue-therapeutics-ltd). Sophymarine's OpenRegistry classifies it under SIC 72110 (Research and experimental development on biotechnology), one of 4,219 active UK entities in that code and one of 11,557 active companies registered in Oxford (postcode OX4). Programmatic access via MCP at https://openregistry.sophymarine.com/mcp.

Status
Active
Type
Private Limited Company
Incorporated
2020-06-04
Registered Address
HAYAKAWA BUILDING, EDMUND HALLEY ROAD, THE OXFORD SCIENCE PARK, OXFORD, OX4 4GB, UNITED KINGDOM
SIC
72110 — Research and experimental development on biotechnology
Country of origin
United Kingdom

Accounts

Last filed accounts made up to 2025-06-30. Next accounts due 2026-09-30. Financial year-end: 31/12. Filing class: SMALL.

Confirmation statement

Last confirmation statement made up to 2025-06-03. Next confirmation statement due 2026-06-17.

Persons with significant control

DARK BLUE THERAPEUTICS LTD has 1 person with significant control on file:

  • Amgen Uk Holdings Limited (United Kingdom reg. 16897338). Notified 2025-12-30.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
    • Has the right to appoint and remove directors

5 historical PSC records have ceased:

  • Bms Strategic Portfolio Investments Holdings, Inc. (United States reg. 599918). Notified 2022-10-17. Ceased 2025-12-30.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Evotec International Gmbh (Germany reg. Hrb 72242). Notified 2022-10-21. Ceased 2024-06-28.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Oxford Science Enterprises Plc (England reg. 09093331). Notified 2020-07-24. Ceased 2022-10-17.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights
  • Dr Andrew James Mclean born 1985 resident in England, British national. Notified 2020-06-04. Ceased 2020-07-24.
    • Owns 75% or more of shares
    • Holds 75% or more of voting rights
    • Has the right to appoint and remove directors
  • Oxford Science Enterprises Plc. Notified 2024-06-28. Ceased 2025-12-30.
    • Owns 25–50% of shares
    • Holds 25–50% of voting rights

Similar UK companies

Other companies registered under SIC 72110 (Research and experimental development on biotechnology):

Other companies registered in Oxford: